145 related articles for article (PubMed ID: 26365933)
1. Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency.
Pleva L; Kusnierova P; Plevova P; Zapletalova J; Karpisek M; Faldynova L; Kovarova P; Kukla P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):586-94. PubMed ID: 26365933
[TBL] [Abstract][Full Text] [Related]
2. Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography.
Huang WC; Teng HI; Chen HY; Wu CJ; Tsai CT; Hsueh CH; Chen YY; Hau WK; Lu TM
Int J Cardiol; 2019 Aug; 289():131-137. PubMed ID: 31079970
[TBL] [Abstract][Full Text] [Related]
3. Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.
Moldoveanu E; Mut-Vitcu B; Tanaseanu GR; Marta DS; Manea G; Kosaka T; Vidulescu C; Tanaseanu C
Clin Biochem; 2008 Dec; 41(18):1429-33. PubMed ID: 18930040
[TBL] [Abstract][Full Text] [Related]
4. Active matrix metalloproteinases 3 and 9 are independently associated with coronary artery in-stent restenosis.
Jones GT; Tarr GP; Phillips LV; Wilkins GT; van Rij AM; Williams MJ
Atherosclerosis; 2009 Dec; 207(2):603-7. PubMed ID: 19576586
[TBL] [Abstract][Full Text] [Related]
5. Intra-individual changes of active matrix metalloproteinase-9 are associated with clinical in-stent restenosis of bare metal stents.
Tarr GP; Williams MJ; Wilkins GT; Chen VH; Phillips LV; van Rij AM; Jones GT
Cardiology; 2013; 124(1):28-35. PubMed ID: 23295453
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis.
Jones GT; Kay IP; Chu JW; Wilkins GT; Phillips LV; McCormick M; van Rij AM; Williams MJ
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):e121-5. PubMed ID: 16690873
[TBL] [Abstract][Full Text] [Related]
7. Could plasma asymmetric dimethylarginine level be a novel predictor beyond the classic predictors of stent restenosis?
Bal UA; Yıldırır A; Aydinalp A; Kaynar G; Kanyilmaz S; Murat K; Müderrisoğlu IH
Anadolu Kardiyol Derg; 2014 Sep; 14(6):491-7. PubMed ID: 25233494
[TBL] [Abstract][Full Text] [Related]
8. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
9. A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.
Ari H; Ari S; Erdoğan E; Tiryakioğlu O; Ustündağ Y; Huysal K; Koca V; Bozat T
Heart Vessels; 2010 Jan; 25(1):19-26. PubMed ID: 20091394
[TBL] [Abstract][Full Text] [Related]
10. The relation of aortic stiffness and in-stent restenosis in patients undergoing percutaneous coronary stenting.
Mahfouz RA; Abdulmoneim A; Abduo M; Elawady W
Echocardiography; 2013 May; 30(5):582-7. PubMed ID: 23565733
[TBL] [Abstract][Full Text] [Related]
11. Role of Gene Polymorphisms/Haplotypes and Plasma Level of TGF-β1 in Susceptibility to In-Stent Restenosis Following Coronary Implantation of Bare Metal Stent in Chinese Han Patients.
Chen HJ; Mo N; Zhang YF; Su GZ; Wu HD; Pei F
Int Heart J; 2018 Jan; 59(1):161-169. PubMed ID: 29332922
[TBL] [Abstract][Full Text] [Related]
12. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
Yildiz A; Tekiner F; Karakurt A; Sirin G; Duman D
Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
[TBL] [Abstract][Full Text] [Related]
13. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
[TBL] [Abstract][Full Text] [Related]
14. The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis.
Pleva L; Kovarova P; Faldynova L; Plevova P; Hilscherova S; Zapletalova J; Kusnierova P; Kukla P
BMC Cardiovasc Disord; 2015 Oct; 15():135. PubMed ID: 26497592
[TBL] [Abstract][Full Text] [Related]
15. Impaired Peripheral Endothelial Function Assessed by Digital Reactive Hyperemia Peripheral Arterial Tonometry and Risk of In-Stent Restenosis.
Komura N; Tsujita K; Yamanaga K; Sakamoto K; Kaikita K; Hokimoto S; Iwashita S; Miyazaki T; Akasaka T; Arima Y; Yamamoto E; Izumiya Y; Yamamuro M; Kojima S; Tayama S; Sugiyama S; Matsui K; Nakamura S; Hibi K; Kimura K; Umemura S; Ogawa H
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27317348
[TBL] [Abstract][Full Text] [Related]
16. Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9.
Katsaros KM; Kastl SP; Zorn G; Maurer G; Wojta J; Huber K; Christ G; Speidl WS
JACC Cardiovasc Interv; 2010 Jan; 3(1):90-7. PubMed ID: 20129576
[TBL] [Abstract][Full Text] [Related]
17. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
[TBL] [Abstract][Full Text] [Related]
18. In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation.
Mizia-Stec K; Gasior Z; Haberka M; Mizia M; Chmiel A; Janowska J; Holecki M; Mielczarek M; Zahorska-Markiewicz B
Kardiol Pol; 2009 Jan; 67(1):9-17; discussion 18. PubMed ID: 19253185
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
[TBL] [Abstract][Full Text] [Related]
20. A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.
Ucar FM
BMC Cardiovasc Disord; 2016 Oct; 16(1):186. PubMed ID: 27716070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
